Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cyran

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Revue D'Epidemiologie Et De Sante Publique|November 1, 2006
[Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France]A Bruandet, D Lucidarme, A Decoster, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 25, 2024
[Motivation and success factors in radiological research in Germany - results of a survey by the Methodology and Research Working Group of the German Radiological Society]Franz Wegner, Helen Heinrichs, Katharina Stahlmann, et al.
Plos One|December 20, 2016
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast CancerPhilipp M Kazmierczak, Andrei Todica, Franz-Josef Gildehaus, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand TherapyFriederike Völter, Lena Mittlmeier, Astrid Gosewisch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumorsHarun Ilhan, S Lindner, A Todica, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial MeningiomasRicarda Ebner, Jana Braach, Johannes Rübenthaler, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2018
<sup>18</sup>F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanomaRalf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, et al.
Academic Radiology|October 17, 2025
Pre- and Periprocedural Imaging Predicts Technical but not Clinical Success of Prostatic Artery Embolization Using Non-spherical PVA Particles-Insights From the Prospective PROEMBO TrialVanessa F Schmidt, Jil Grethen, Mariya Pryadko, et al.
Molecular Imaging and Biology|October 16, 2025
[<sup>18</sup>F]FDG-PET/CT Imaging for Response Characterisation of Experimental Melanomas to Anti-PD-L1/Anti-CTLA-4 ImmunotherapyMelissa J Antons, Sandra Kloiber-Langhorst, Heidrun Hirner-Eppeneder, et al.
Plos One|July 1, 2025
Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring combined anti-PD-L1/anti-CTLA-4 immunotherapy effects in a murine melanoma model with immunohistochemical validationFelix L Herr, Melissa J Antons, Larissa V Blume, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Revue D'Epidemiologie Et De Sante Publique|November 1, 2006
[Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France]A Bruandet, D Lucidarme, A Decoster, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 25, 2024
[Motivation and success factors in radiological research in Germany - results of a survey by the Methodology and Research Working Group of the German Radiological Society]Franz Wegner, Helen Heinrichs, Katharina Stahlmann, et al.
Plos One|December 20, 2016
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast CancerPhilipp M Kazmierczak, Andrei Todica, Franz-Josef Gildehaus, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand TherapyFriederike Völter, Lena Mittlmeier, Astrid Gosewisch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumorsHarun Ilhan, S Lindner, A Todica, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial MeningiomasRicarda Ebner, Jana Braach, Johannes Rübenthaler, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2018
<sup>18</sup>F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanomaRalf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, et al.
Academic Radiology|October 17, 2025
Pre- and Periprocedural Imaging Predicts Technical but not Clinical Success of Prostatic Artery Embolization Using Non-spherical PVA Particles-Insights From the Prospective PROEMBO TrialVanessa F Schmidt, Jil Grethen, Mariya Pryadko, et al.
Molecular Imaging and Biology|October 16, 2025
[<sup>18</sup>F]FDG-PET/CT Imaging for Response Characterisation of Experimental Melanomas to Anti-PD-L1/Anti-CTLA-4 ImmunotherapyMelissa J Antons, Sandra Kloiber-Langhorst, Heidrun Hirner-Eppeneder, et al.
Plos One|July 1, 2025
Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring combined anti-PD-L1/anti-CTLA-4 immunotherapy effects in a murine melanoma model with immunohistochemical validationFelix L Herr, Melissa J Antons, Larissa V Blume, et al.
Pageof 14